NIAID Site Search

This document provides an overview of research and training programs opportunities for 2022-2023 available through the Division of Intramural Research.

Last Reviewed: November 3, 2022

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

This document provides a summary of the NIAID Expert Panel Review on Medical Chemical Defense Research on March 19, 2003.

Last Reviewed: March 19, 2003

NIH Opening Statement Senate LHHS FY 2019 Hearing: Prepared statement of Lawrence A. Tabak, D.D.S., PH.D., Principal Deputy Director, Office of the Director

Last Reviewed: August 16, 2018

NIH strategic plan to develop medical countermeasures against possible terrorist attacks involving radioactive materials.

Last Reviewed: December 5, 2019

The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and

Last Reviewed: February 5, 2024